WINKAST-250 INHALER
MRP: 765
Packaging: 120 MD
Pack Type: inhaler
Composition:
Fluticasone Propionate 250mg + Salmeterol 25mg
Indication:
Asthma, COPD
Description:
Fluticasone Propionate 250 mcg + Salmeterol 25 mcg is a fixed-dose combination inhaler designed for the long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). Fluticasone is a potent corticosteroid that reduces inflammation in the airways, while Salmeterol is a long-acting beta-2 adrenergic agonist (LABA) that helps to relax the muscles in the airways, making breathing easier. This synergistic combination helps control symptoms, reduce flare-ups, and improve overall lung function.
Tags:
- Dual action: reduces inflammation and opens airways
- Helps prevent asthma attacks and COPD exacerbations
- Improves lung function and exercise tolerance
- Reduces hospitalizations due to chronic respiratory conditions
- Convenient twice-daily dosing
Usage Information
Dosage
Adults (Asthma/COPD): 1 inhalation twice daily or as prescribed Use with: Dry powder inhaler (DPI) or metered-dose inhaler (MDI) Administration tips: Shake well (for MDI) Rinse mouth after use to avoid oral thrush Use a spacer if needed (for MDI)
Side Effects
Hoarseness or throat irritation Oral thrush (fungal infection) Headache Palpitations Muscle cramps Cough Serious but rare: Allergic reactions, paradoxical bronchospasm, adrenal suppression (long-term high doses)
Contraindications
Known allergy to fluticasone, salmeterol, or excipients Not for relief of acute bronchospasm Use with caution in: Patients with active pulmonary infections Cardiovascular disorders Hyperthyroidism Diabetes mellitus